Role of Academic labs Flashcards
What is a New Chemical Entity?
It is a drug that is proven to be safe, effective, and has been approved, or an already approved drug that has a different new use.
How long and how much does it cost to produce a new drug?
About 15 years and 1.5 billion dollars.
What happens on Clinical Trial Phase 1?
The drugs is tested for safety and pharmacokinetics in volunteer humans.
What happens on Clinical Trial Phase 2?
The drug is tested on larger groups of humans for dosage requirements and pharmacodynamics.
What happens on Clinical Trial Phase 3?
The drug is tested with large groups of humans in order to establish if the drug is better than the gold standard?treatment.
What is the Proof of Concept performed on phase 2 of clinical trials?
It is the phase where the drug is demonstrated to have a module leads to a desirable clinical outcome in terms of efficacy, safety and dosage.
What is the challenge presented with NCE?
The challenge is to find a drug that is worth the investment, without making large investments in targets and drugs that will ultimately fail.
What is an example of an academic discovery?
3-hydroxy-3-methyl-glutaryl-CoA reductase in the metabolism of cholesterol lead to the production of statins.
What are statins?
Mevacor, Lovastatin and Zacor by Merck block the receptor for the resucitase and reduce colesterol in the blood.
What is confidence in rational and safety?
It presents evidence that a certain drug hits the target in an effective and safe way.
Why statins needed confidence in rational and safety?
Because mice developed tumours in the liver.
What is the most famous medicine in the world?
Atorvastatin
What is an example of another NCE but statins?
Rutixan. It was used to treat multiple sclerosis and now it is used to treat cancer.
What are three technologies developed in academic labs:
siRNA-used in the validation of targets
Embryonic stem cell-in vitro models of diseases
CRISPR- used to gene editing
What large companies can do that labs can’t?
Excel the later stages of processes in product developments such as clinical trials.